Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTO-201 Trans-Tympanostomy Tube Administration Study
NCT02350998Phase 3Completed
- Sponsor
- Otonomy, Inc.
- Start
- Jan 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ciprofloxacin in otitis media with effusion (OME), sponsored by Otonomy, Inc. Primary endpoints: Otoscopic Examination: Auricle and Meatus at 1 month, Otoscopic Examination: Tympanic Membrane at 1 month and 1 more. Started Jan 2015; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT02350998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350998.